Holen Sie sich die Stockscreener-App
5.14
6.72%
-0.37
Handel nachbörslich:
5.20
0.06
+1.17%
Schlusskurs vom Vortag:
$5.51
Offen:
$5.52
24-Stunden-Volumen:
1.72M
Relative Volume:
1.32
Marktkapitalisierung:
$714.03M
Einnahmen:
$62.04M
Nettoeinkommen (Verlust:
$-533.34M
KGV:
-1.3112
EPS:
-3.92
Netto-Cashflow:
$-473.07M
1W Leistung:
+1.98%
1M Leistung:
+0.78%
6M Leistung:
-37.32%
1J Leistung:
-32.37%
1-Tages-Spanne:
$5.04
$5.638
1-Wochen-Bereich:
$4.86
$5.638
52-Wochen-Spanne:
$4.155
$14.45
Vir Biotechnology Inc Stock (VIR) Company Profile
Firmenname
Vir Biotechnology Inc
Sektor
Branche
Telefon
415-906-4324
Adresse
1800 OWENS STREET, SAN FRANCISCO, CA
Vergleichen Sie VIR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VIR
Vir Biotechnology Inc
|
5.14 | 694.58M | 62.04M | -533.34M | -473.07M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-03-06 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-02-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-01-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | Eingeleitet | SVB Leerink | Outperform |
| 2022-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-03-03 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2021-12-21 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2021-10-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Neutral |
| 2021-01-27 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-20 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-05 | Eingeleitet | BofA Securities | Buy |
| 2020-09-14 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-11 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-08-20 | Eingeleitet | Needham | Buy |
| 2020-03-19 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-13 | Herabstufung | Goldman | Buy → Neutral |
| 2020-02-27 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-02-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-11-14 | Eingeleitet | Robert W. Baird | Neutral |
| 2019-11-05 | Eingeleitet | Barclays | Overweight |
| 2019-11-05 | Eingeleitet | Cowen | Outperform |
| 2019-11-05 | Eingeleitet | Goldman | Buy |
| 2019-11-05 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Vir Biotechnology Inc Aktie (VIR) Neueste Nachrichten
Vir Biotechnology: A Contrarian Buy in a High-Risk, High-Reward Biotech Play - AInvest
The Play On Vir Biotechnology (NASDAQ:VIR) - Seeking Alpha
Vir Biotechnology (VIR.O) Surges 7.3%—What’s Behind the Intraday Move? - AInvest
Vir Biotechnology Director Sells 22K Shares at $4.99 on 2025-09-02. - AInvest
Vir Biotechnology Surges 5.1% — But No Technical Signals Fired — Here’s What Could Be Behind It - AInvest
Should you wait for a breakout in Vir Biotechnology Inc.Market Weekly Review & Verified Chart Pattern Trade Signals - Newser
Analyzing recovery setups for Vir Biotechnology Inc. investors2025 Market Sentiment & Smart Investment Allocation Tips - Newser
Vir Biotechnology Inc. stock momentum explained2025 Investor Takeaways & Weekly Top Gainers Alerts - Newser
What are the analyst revisions for Vir Biotechnology Inc.Is LBTYB stock a good investment in YEAR2025 Top Gainers & Weekly High Conviction Trade Ideas - khodrobank.com
Trend analysis for Vir Biotechnology Inc. this weekRate Hike & Consistent Income Trade Ideas - Newser
Using Bollinger Bands to evaluate Vir Biotechnology Inc.Bull Run & Low Drawdown Trading Techniques - Newser
How sentiment analysis helps forecast Vir Biotechnology Inc.Weekly Profit Summary & Real-Time Buy Signal Notifications - Newser
Forecasting Vir Biotechnology Inc. price range with options dataWeekly Investment Summary & Low Risk High Reward Trade Ideas - Newser
What to expect from Vir Biotechnology Inc. in the next 30 daysPortfolio Update Summary & Proven Capital Preservation Methods - Newser
What earnings revisions data tells us about Vir Biotechnology Inc.2025 Momentum Check & Reliable Intraday Trade Plans - Newser
Heatmap analysis for Vir Biotechnology Inc. and competitorsMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - Newser
Real time social sentiment graph for Vir Biotechnology Inc.Quarterly Performance Summary & Smart Allocation Stock Tips - Newser
Vir Biotechnology Inc. stock prediction for this weekMarket Risk Analysis & High Accuracy Swing Entry Alerts - Newser
Using data tools to time your Vir Biotechnology Inc. exitJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - Newser
What MACD signals say about Vir Biotechnology Inc.Dip Buying & AI Enhanced Trading Alerts - Newser
Does Vir Biotechnology Inc. stock benefit from AI growthJuly 2025 Movers & Fast Gaining Stock Strategy Reports - khodrobank.com
Is it time to cut losses on Vir Biotechnology Inc.Rate Hike & Reliable Price Breakout Signals - Newser
Why Vir Biotechnology Inc. stock attracts strong analyst attentionWeekly Trade Review & AI Driven Price Predictions - Newser
Analyzing net buyer seller activity in Vir Biotechnology Inc.July 2025 PostEarnings & Real-Time Volume Analysis - Newser
Using fundamentals and technicals on Vir Biotechnology Inc.Product Launch & Stepwise Entry/Exit Trade Alerts - Newser
Can Vir Biotechnology Inc. ride the EV waveEarnings Performance Report & Technical Pattern Recognition Alerts - khodrobank.com
Does Vir Biotechnology Inc. qualify in momentum factor screeningTrade Signal Summary & Real-Time Volume Triggers - Newser
What is Vir Biotechnology Inc. s revenue forecastJuly 2025 Highlights & Free Safe Capital Growth Stock Tips - khodrobank.com
Vir Biotechnology’s SWOT analysis: promising pipeline buoys stock amid challenges - Investing.com
Earnings visualization tools for Vir Biotechnology Inc.Quarterly Risk Review & Smart Money Movement Alerts - Newser
Will Vir Biotechnology Inc. outperform the market in YEARMarket Growth Review & Stock Timing and Entry Methods - khodrobank.com
Vir Biotechnology Inc. Recovers — But Is It Sustainable getLinesFromResByArray error: size == 0 - thegnnews.com
How to integrate Vir Biotechnology Inc. into portfolio analysis toolsProfit Target & Community Consensus Trade Alerts - Newser
Advanced analytics toolkit walkthrough for Vir Biotechnology Inc.2025 Winners & Losers & Detailed Earnings Play Strategies - Newser
Market reaction to Vir Biotechnology Inc.’s recent newsJuly 2025 Earnings & Daily Risk Controlled Trade Plans - Newser
Is Vir Biotechnology Inc. stock entering bullish territoryJuly 2025 Breakouts & Real-Time Market Trend Scan - Newser
Can Vir Biotechnology Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - 더경남뉴스
Vir Biotechnology Inc. Uptrend in Early Stages Indicators Say Yes getLinesFromResByArray error: size == 0 - newsyoung.net
Finanzdaten der Vir Biotechnology Inc-Aktie (VIR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vir Biotechnology Inc-Aktie (VIR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SATO VICKI L | Director |
Aug 01 '25 |
Sale |
4.99 |
22,000 |
109,699 |
1,276,391 |
| Eisner Mark | EVP and Chief Medical Officer |
Jul 15 '25 |
Sale |
5.47 |
6,796 |
37,162 |
108,204 |
| Eisner Mark | EVP and Chief Medical Officer |
Jul 17 '25 |
Sale |
5.47 |
3,586 |
19,629 |
104,618 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):